CHU Bordeauxt

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Liver and biliary tract cancer

Closed trials

• Completed

  Ezurpimtrostat autophagy inhibitor in association with Atezolizumab-Bevacizumab in first line treatment of unresectable hepatocellular carcinoma, a phase 2b randomized trial. ABE-LIVER

  NCT05448677· Phase 2· Centre Hospitalier Universitaire De Grenoble· Source